Linglin Zou

534 total citations
16 papers, 313 citations indexed

About

Linglin Zou is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Linglin Zou has authored 16 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Linglin Zou's work include Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). Linglin Zou is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Mechanisms and Therapy (2 papers). Linglin Zou collaborates with scholars based in China, Iran and Canada. Linglin Zou's co-authors include Xinna Deng, Ye Su, Anthony M. Jevnikar, Zhu‐Xu Zhang, Alexander Pavlosky, Haijiang Wu, Leisheng Zhang, Lei Zhang, Baoquan Song and Zhongchao Han and has published in prestigious journals such as Frontiers in Immunology, Food and Chemical Toxicology and BMC Genomics.

In The Last Decade

Linglin Zou

16 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linglin Zou China	8	174	127	59	51	47	16	313
Luigi Tomao Italy	11	177 1.0×	152 1.2×	66 1.1×	79 1.5×	44 0.9×	22	398
Cinzia Candiotto Italy	8	130 0.7×	77 0.6×	119 2.0×	89 1.7×	77 1.6×	9	378
Shunli Ding France	5	192 1.1×	66 0.5×	56 0.9×	77 1.5×	63 1.3×	6	352
Michiru Kobori Japan	6	252 1.4×	61 0.5×	117 2.0×	64 1.3×	73 1.6×	7	389
Clément d’Audigier France	11	228 1.3×	68 0.5×	84 1.4×	42 0.8×	77 1.6×	15	427
Yo Iwami Japan	4	228 1.3×	59 0.5×	65 1.1×	59 1.2×	58 1.2×	4	346
Haoran Shi China	9	138 0.8×	76 0.6×	34 0.6×	88 1.7×	122 2.6×	17	359
Jun Watanabe Japan	11	208 1.2×	72 0.6×	160 2.7×	55 1.1×	31 0.7×	35	478
Pasquale Creo Italy	12	244 1.4×	130 1.0×	37 0.6×	40 0.8×	111 2.4×	20	449
Tremika L.S. Wilson United States	5	153 0.9×	166 1.3×	77 1.3×	79 1.5×	34 0.7×	7	371

Countries citing papers authored by Linglin Zou

Since Specialization

Citations

This map shows the geographic impact of Linglin Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linglin Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linglin Zou more than expected).

Fields of papers citing papers by Linglin Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linglin Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linglin Zou. The network helps show where Linglin Zou may publish in the future.

Co-authorship network of co-authors of Linglin Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Linglin Zou. A scholar is included among the top collaborators of Linglin Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linglin Zou. Linglin Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zou, Linglin, et al.. (2024). A review: Blood pressure monitoring based on PPG and circadian rhythm. APL Bioengineering. 8(3). 31501–31501. 3 indexed citations

Fan, Yu, Linglin Zou, Xiaorong Zhong, et al.. (2023). Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment. BMC Genomics. 24(1). 391–391. 1 indexed citations

Han, Li, et al.. (2023). Dermal repeated dose toxicity study of the anti-breast cancer drug Formestane cream in Bama minipig. Food and Chemical Toxicology. 178. 113927–113927. 1 indexed citations

Zhang, Xinyi, Linglin Zou, Duoli Zhang, et al.. (2023). Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment. Cell Communication and Signaling. 21(1). 190–190. 49 indexed citations

Zhu, Lei, Chen Shen, Xiaoming Hou, et al.. (2023). The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment. Frontiers in Immunology. 14. 1041525–1041525. 6 indexed citations

Yang, Liqiong, Duoli Zhang, Fukuan Du, et al.. (2022). Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer. Frontiers in Oncology. 12. 7 indexed citations

Zhang, Leisheng, Ying Chi, Yimeng Wei, et al.. (2021). Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality. Stem Cell Research & Therapy. 12(1). 365–365. 38 indexed citations

Zhang, Leisheng, Linglin Zou, Chunjing Feng, et al.. (2020). Multifaceted modifications for a cell size‐based circulating tumor cell scope technique hold the prospect for large‐scale application in general populations. Cell Biology International. 45(2). 345–357. 7 indexed citations

Zou, Linglin, Saber İmani, Mazaher Maghsoudloo, et al.. (2020). Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis. Oncology Reports. 44(3). 1075–1093. 10 indexed citations

10.

Zhao, Qinjun, Leisheng Zhang, Yimeng Wei, et al.. (2019). Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease. Stem Cell Research & Therapy. 10(1). 354–354. 63 indexed citations

11.

Zhang, Zhenhua, Saber İmani, Marzieh Dehghan Shasaltaneh, et al.. (2019). The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis. BMC Cancer. 19(1). 1134–1134. 21 indexed citations

12.

Su, Ye, Haijiang Wu, Alexander Pavlosky, et al.. (2016). Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death and Disease. 7(8). e2333–e2333. 91 indexed citations

13.

Shao, Yi, et al.. (2014). Fast-track surgery for gastroenteric neoplasms: a meta-analysis.. PubMed. 100(5). e197–203. 5 indexed citations

14.

Shao, Yi, et al.. (2014). Fast-track Surgery for Gastroenteric Neoplasms: A Meta-analysis. Tumori Journal. 100(5). e197–e203. 4 indexed citations

15.

Zou, Linglin, et al.. (2011). Sorafenib for advanced hepatocellular carcinoma: a systematic review.. PubMed. 33(1). 51–7. 5 indexed citations

16.

Shi, Xu, Linglin Zou, Dongsheng Xiong, et al.. (2008). Influence of the calmodulin antagonist EBB on cyclin B1 and Cdc2-p34 in human drug-resistant breast cancer MCF-7/ADR cells. Chinese Journal of Clinical Oncology. 5(2). 108–112. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact